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1Editorial
Pancreatic cystic neoplasia
All too often a pancreatic tumour turns out to be the
common type of ductal adenocarcinoma, with its strong
potential for early invasion and metastasis and the con-
sequent infrequency of cure. The incidence of neuro-
endocrine tumours of the pancreas roughly reflects the
proportion of endocrine tissue within the gland (less than
5%). Separation between benign and malignant variants
of neuroendocrine tissue is influenced by the size of the
tumour. In ‘borderline’ cases the distinction may be made
as easily by the operating surgeon who finds evidence of
nodal or hepatic metastases as by the histopathologist
looking down the microscope. It may be best to consider
all neuroendocrine tumours as potentially malignant,
though in the case of insulinoma the risk is less than
10%. En passant, I wonder whether any other tumour in
the body that is as small as the average insulinoma or
gastrinoma can cause such devastating systemic effects.
The only other pancreatic tumour that occurs with any
degree of frequency is a cystic neoplasm. These interesting
lesions embrace a number of different subtypes, three of
which formed the subject of reports in the last issue of this
journal, while a fourth was described in a paper published
in 2000. Some ‘ordinary’ ductal carcinomas can present a
cystic appearance on imaging because of central necrosis,
and from time to time a neuroendocrine tumour will also
undergo cystic degeneration. These curiosities apart, there
are four main variants of pancreatic cystic neoplasm. Of
these, the most innocuous is serous cystadenoma, though
even here malignant transformation is a remote possibility.
This tumour is also known as microcystic adenoma, and its
honeycomb appearance on CT may allow quite a confident
preoperative diagnosis. Indeed, since these lesions often
arise in elderly women, a typical appearance on imaging
may deter the surgeon from undertaking a major pancreatic
resection.
Mucinous cystic tumours are much less innocent than
their serous counterparts. They show a gradation from a
truly benign neoplasm (cystadenoma) through a localised
malignancy (cystadenocarcinoma) to an advanced, inva-
sive cancer. Other things being equal, therefore, mucinous
tumours should be resected whatever their site of origin
within the gland. Fortunately, in this regard, they tend to
affect the middle-aged more often than the elderly.
Papillary-cystic neoplasm has almost as many synonyms as
case reports. It is both rare and virtually confined to young
women. As the name suggests, solid and cystic components
are combined within the tumour, which should be regarded
as one of low-grade malignancy. The fourth type of cystic
neoplasm is now termed intraductal papillary mucinous
tumour or IPMT. The alternative label – mucinous ductal
ectasia – draws attention to its main characteristic, namely
a grossly dilated pancreatic duct that is full of mucin.
Extrusion of mucin through the papilla at duodenoscopy is
the crucial clue that the patient (usually a man) may have
not just florid chronic pancreatitis but an underlying neo-
plasm with a dinstinct potential to undergo malignant
change.
What can be learned about these pancreatic ‘fascinomas’
from the four papers that we have recently published?
Fischer and colleagues from Edinburgh, UK, describe a
44-year-old woman with a mucinous cystadenoma of the
pancreas who presented with acute pancreatitis [1]. She
had a sudden onset of pain and vomiting with epigastric
tenderness and a raised serum amylase. Imaging revealed a
mature cyst in the tail of pancreas with peripancreatic
inflammation and (remarkably) concomitant infarction of
the spleen. The authors were rightly suspicious about the
nature of this lesion and proceeded to remove the distal
pancreas and spleen. Within the wall of the cyst there was
a small focus of mucinous cystadenoma with ovarian-type
stroma. This case is rather disquieting. In trying to distin-
guish a cystic neoplasm from an inflammatory psuedocyst,
one usually relies on the absence of an antecedent history
of acute and chronic pancreatitis (as well as the contour
of the cyst on scanning). Thus the recent acute pancreati-
tis should really have ruled out the diagnosis of cystic
neoplasm in this patient. The authors speculate that
obstruction of the pancreatic duct by the small tumour
may have triggered the attack of pancreatitis; alternatively
this was a truly idiopathic attack and the cyst was an inci-
dental (if fortuitous) discovery. Of course it has long been
known that acute pancreatitis is occasionally caused by car-
cinoma of the ampulla, and I have encountered the same
association with endocrine tumours.
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Chedid and his associates from Porto Alegre, Brazil
report another case of papillary cystic neoplasm in a young
woman [2]. Notable features were her relative youth (18
years) and the fact that the site of origin within the pan-
creatic head necessitated a Whipple’s operation. They
suggest a hormonal influence to explain the particular
propensity for this tumour to affect women of reproductive
age. The histogenesis of papillary cystic neoplasm is
obscure; both acinar, ductal and endocrine cells have been
considered as the cell of origin, together with an undiffer-
entiated progenitor cell. The rarity of these tumours does
not facilitate detailed studies!
From Aarhus, Denmark, comes a report of six cases of
IPMT described by Bendix Holme and associates [3]. All
six patients had diffuse dilatation of the main pancreatic
duct, and all six were treated by total pancreatectomy. A
seventh patient had liver metastases and was not operated;
he lived another 17 months. In contradistinction to the
other types of cystic neoplasm of the pancreas, each case
of IPMT affected a male patient (median age 68 years).
For myself, I have seen two new cases of IPMT in the last
year, one in a man of 65 years and one in a woman of 81
years. In each case mucin was seen coming through the
papilla at endoscopy, though the younger patient also had
a localised cyst ulcerating into the duodenum which could
have been a mucinous cystadenocarcinoma or even a
chronic pseduocyst. Proximal pancreatoduodenectomy was
converted into a total pancreatic resection when frozen-
section histology of the duct at the resection margin
showed invasive IPMT. This experience inclines me to
accept the suggestion from the Danish group that total
pancreatectomy is the treatment of choice for this condi-
tion. They point out that IPMT patients usually have
symptoms of chronic pancreatitis, which helps to justify
such radical treatment.
To complete the survey of cystic neoplasms I will refer
to a paper by Formentini and colleagues from Ulm,
Germany that we published in early 2000 [4]. They
described a series of 25 patients with serous cystic neo-
plasms of the pancreas who had undergone operation over
a 12-year period. Three of these tumours were serous cys-
tadenocarcinomas, while another two benign serous
cystadenomas were associated with ductal cancers. This
experience is a timely warning that serous tumours are not
always innocent lesions.
It is my belief that the increasing use of ultrasound and
CT scanning to pursue unexplained abdominal pain will
increase the yield of patients presenting with resectable cys-
tic neoplasms of the pancreas. I have lately seen two such
lesions that were detected on routine antenatal scans in
pregnant women. Congenital pancreatic cyst might be a
reasonable differential diagnosis in such a case, but this
condition seems even rarer, at least as an isolated lesion.
The most important conclusion to be drawn from this
crop of cases is as follows: Beware the diagnosis of
pseudocyst in a patient without either a documented
attack of acute pancreatitis or clear-cut aetiological factors
to support a diagnosis of pancreatitis. The outcome is
bound to be unsatisfactory when the surgeon assumes that
a cystic neoplasm in or adjacent to the pancreas is inflam-
matory in origin and fails to carry out any (or adequate)
biopsy of its wall [5]. Under these circumstances an inter-
nal drainage procedure is doomed to failure whether
stomach or jejunum is used or, as I have seen on two
occasions, stomach followed by jejunum at successive
operations.
Robin Williamson
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